Acute severe hypertension (ASH), post-hospitalization BP management
KARDKardigan™Catalyst overview
Research summary
This catalyst tracks a Phase 2 data readout for Tonlamarsen in Acute severe hypertension (ASH), post-hospitalization BP management. The expected timing is based on the latest available company guidance and may change.
KARDINAL-ASH trial. 03/28/26:- Showed significant AGT reduction and clinically meaningful oSBP lowering. 06/11/26:- Trial ongoing; Ph2b topline data in H1 2027. 08/12/26:- KARDINAL-ASH first patient randomized. Ph2 topline data expected in H1 2027.
Verification
Confirm timing and program details against the company announcement or filing.